From Targets to Treatments: A Review of Molecular Targets in Pancreatic Neuroendocrine Tumors
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Targets to Treatments: A Review of Molecular Targets in Pancreatic Neuroendocrine Tumors
Authors
Keywords
-
Journal
NEUROENDOCRINOLOGY
Volume 94, Issue 3, Pages 177-190
Publisher
S. Karger AG
Online
2011-08-31
DOI
10.1159/000329386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists
- (2010) Thomas Troxler et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
- (2010) Dusan Djokovic et al. BMC CANCER
- First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
- (2010) Jonathan R. Strosberg et al. CANCER
- High expression of dopamine receptor subtype 2 in a large series of neuroendocrine tumors
- (2010) Erika Grossrubatscher et al. CANCER BIOLOGY & THERAPY
- Incidence rates of exocrine and endocrine pancreatic cancers in the United States
- (2010) Jing Zhou et al. CANCER CAUSES & CONTROL
- Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas
- (2010) Nicola Fazio et al. CANCER TREATMENT REVIEWS
- Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors
- (2010) K. M. Detjen et al. CLINICAL CANCER RESEARCH
- New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?
- (2010) Barbro Eriksson CURRENT OPINION IN ONCOLOGY
- The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors
- (2010) Nicté Figueroa-Vega et al. ENDOCRINE-RELATED CANCER
- Internalized Somatostatin Receptor Subtype 2 in Neuroendocrine Tumors of Octreotide-Treated Patients
- (2010) Jean Claude Reubi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
- (2010) Diane Lauren Reidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis
- (2010) Christopher W. Chiu et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours
- (2010) Srirajaskanthan ONCOLOGY REPORTS
- KIT is an Independent Prognostic Marker for Pancreatic Endocrine Tumors
- (2009) Lizhi Zhang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
- (2009) J. B. Cwikla et al. ANNALS OF ONCOLOGY
- Inhibition of Phosphatidylinositol 3-Kinase/Akt Signaling Suppresses Tumor Cell Proliferation and Neuroendocrine Marker Expression in GI Carcinoid Tumors
- (2009) Susan C. Pitt et al. ANNALS OF SURGICAL ONCOLOGY
- Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists
- (2009) Thomas Troxler et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis
- (2009) R Srirajaskanthan et al. ENDOCRINE-RELATED CANCER
- Is It Time to Widen the Use of Somatostatin Analogs in Neuroendocrine Tumors?
- (2009) Kjell E. Öberg JOURNAL OF CLINICAL ONCOLOGY
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors
- (2009) Matthias D Hofer et al. MODERN PATHOLOGY
- Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies
- (2009) R. Srirajaskanthan et al. NEUROENDOCRINOLOGY
- Expression Pattern and Functional Relevance of Epidermal Growth Factor Receptor and Cyclooxygenase-2: Novel Chemotherapeutic Targets in Pancreatic Endocrine Tumors?
- (2008) Frank Bergmann et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
- (2008) Mark Kidd et al. CANCER
- Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
- (2008) S. Grozinsky-Glasberg et al. ENDOCRINE-RELATED CANCER
- Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
- (2008) Dorota Dworakowska et al. ENDOCRINE-RELATED CANCER
- Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
- (2008) David C. Metz et al. GASTROENTEROLOGY
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst1 receptor
- (2007) Thomas Troxler et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line
- (2007) Simona Grozinsky-Glasberg et al. NEUROENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started